Skip to main content

Day: April 21, 2020

Umicore – Modifications aux modalités de participation aux assemblées générales du 30 avril 2020 dans le cadre des mesures Covid-19

Suite à la pandémie Covid-19, l’attention prioritaire d’Umicore va à la sécurité de ses actionnaires, ses employés et autres parties prenantes (« stakeholders »). Dans ce but et suite à l’adoption de l’Arrêté Royal n° 4 du 9 avril 2020 portant des dispositions diverses en matière de droit des sociétés dans le cadre de la lutte contre la pandémie Covid-19, le conseil d’administration d’Umicore a décidé de modifier les modalités de participation aux assemblées ordinaire, spéciale et extraordinaire du jeudi 30 avril prochain (ainsi qu’à l’assemblée extraordinaire des actionnaires éventuellement à tenir le mercredi 3 juin prochain, au cas où le quorum de présence ne serait pas atteint au 30 avril prochain).Les nouvelles modalités de participation sont élaborées dans la convocation amendée qui peut être consultée sur le site internet d’Umicore.Les...

Continue reading

Umicore – Wijzigingen in de modaliteiten voor deelname aan de algemene vergaderingen van 30 april 2020 in het kader van de Covid-19 maatregelen

Naar aanleiding van de globale uitbraak van Covid-19, gaat Umicore’s prioritaire aandacht naar de veiligheid van haar aandeelhouders, werknemers en andere stakeholders. Met dat doel voor ogen  heeft de raad van bestuur van Umicore, na de inwerkingtreding van het Koninklijk Besluit nr. 4 van 9 april 2020 houdende diverse bepalingen inzake het vennootschapsrecht in het kader van de strijd tegen de Covid-19 pandemie, beslist om de deelnamemodaliteiten met betrekking tot de gewone, bijzondere en buitengewone algemene vergaderingen van donderdag 30 april a.s. (en eventueel de op woensdag 3 juni 2020 te houden buitengewone algemene vergadering, indien het aanwezigheidsquorum op 30 april a.s. niet bereikt zou zijn) te wijzigen.De nieuwe modaliteiten van deelname worden toegelicht in de aangepaste oproeping die kan geraadpleegd worden op onze...

Continue reading

MISE À JOUR : Le Comité d’investissement communautaire de TELUS à Québec remet 135 000 $ à des organismes communautaires pour les aider à faire face à la COVID-19

QUÉBEC, 21 avr. 2020 (GLOBE NEWSWIRE) — Le Comité d’investissement communautaire de TELUS à Québec a annoncé aujourd’hui qu’il versait 135 000 $ en dons à des organismes communautaires locaux pour les aider à faire face à la pandémie de COVID-19 et qu’il s’engageait à verser un montant supplémentaire de 265 000 $, pour un total de 400 000 $ en 2020. Les trois comités d’investissement communautaire de TELUS au Québec remettront 1,3 million de dollars à des dizaines d’organismes aux quatre coins de la province afin d’épauler les clients et les collectivités alors qu’ils sont confrontés à l’adversité.« En cette période sans précédent, l’impact positif du secteur communautaire est plus essentiel que jamais. Alors que les organismes ajustent rapidement leur capacité à répondre aux besoins, l’appui financier du Comité d’investissement...

Continue reading

Fnac Darty : mise à disposition du Document d’enregistrement universel 2019

 INFORMATION RÉGLEMENTÉEMISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2019Fnac Darty vous informe que le document d’enregistrement universel établi pour l’exercice clos le 31 décembre 2019 a été déposé le 20 avril 2020 auprès de l’Autorité des Marchés Financiers.Il intègre notamment les informations suivantes : Le rapport financier annuel 2019,Le rapport sur le gouvernement d’entreprise,Le descriptif du programme de rachat d’actions.Au cours du mois de février 2020,  l’organisation mondiale de la santé a qualifié la situation liée à la propagation du Covid-19 de pandémie, entrainant des confinements de population dans de nombreux pays du globe. En conséquence, le Document d’enregistrement universel a été mis à jour depuis le rapport de gestion et l’arrêté des comptes du 26 février 2020, date de la publication des comptes et...

Continue reading

Fnac Darty: filing of the 2019 Universal registration document

 REGULATED INFORMATIONFILING OF THE 2019 UNIVERSAL REGISTRATION DOCUMENTFnac Darty announces that it registered its 2019 Universal Registration Document (Document d’enregistrement universel) with the French Autorité des Marchés Financiers (AMF) on 20 April 2020.The 2019 Universal Registration Document includes:The 2019 financial report;The 2019 Corporate Governance report;The description of the share repurchase program.In February 2020, the World Health Organization described the situation related to the spread of Covid-19 as a pandemic, resulting in population lockdown in many countries around the world. As a result, the Universal Registration Document has been updated since the Management Report and the closing of the financial statements on 26 February 2020, the date of publication of the financial statements and the assumptions underlying...

Continue reading

Recruiter.com Index Predicts Rise of Hiring Demand within 90 Days

HOUSTON, April 21, 2020 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB:RCRT), a leading recruiting platform, today announced that Recruiter Index®, Recruiter.com’s proprietary analysis that pinpoints recruiting trends and forecasts business growth, shows that a significant number of recruiters expect increasing job requirements within the next 90 days.Rick Roberts, President of Recruiting Solutions said, “Our network platform gives us special insight into areas of business that show the most potential for growth. Informed by our network, during the past few weeks, we are excited to have opened up a record number of jobs and significantly increased resume submissions from our network of recruiters.”Recruiter.com regularly gathers data from its network of over 20,000 small and independent recruiters to uncover critical insights...

Continue reading

CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 21, 2020 (GLOBE NEWSWIRE) — CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the production and global distribution of CentoSwab™. This sample collection kit is fully validated for pharyngeal sampling in the detection of SARS-CoV-2, which causes COVID-19. Manufactured in Germany, the kit consists of a sterile package containing a swab and collection tube. This solution is part of the Company’s global initiative to support the logistics and fast diagnosis of COVID-19 as early as possible.Prof. Arndt Rolfs, CEO of the Company, stated, “We are all interested in stopping the COVID-19 outbreak. The critical...

Continue reading

CPSI to Broadcast Its First Quarter 2020 Conference Call Live on the Internet

MOBILE, Ala., April 21, 2020 (GLOBE NEWSWIRE) — CPSI (NASDAQ: CPSI), a community healthcare solutions company, today announced that it will release its financial results for the first quarter ended March 31, 2020, on Tuesday, May 5, 2020, after the market closes. The Company will also host a conference call at 4:30 p.m. Eastern Time that same day.The live broadcast of CPSI’s conference call will be available online at the Company’s website, www.cpsi.com. The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.About CPSICPSI is a leading provider of healthcare solutions and services for community hospitals, their clinics and post‑acute care facilities. Founded in 1979, CPSI is the parent of four companies – Evident, LLC, American HealthTech, Inc., TruBridge, LLC, and Get Real...

Continue reading

Aequus Announces Positive Update on Dry Eye Product Launch Plans

VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to announce a positive update on the regulatory and launch advancement for the Evolve® line of preservative free dry eye products into Canada.Medicom Healthcare, the UK manufacturer of Evolve® products, has received a positive outcome of the Audit to meet standards for the Canadian Medical Device Single Audit Program (MDSAP). The MDSAP, fully implemented by Health Canada in January 2019, establishes a new audit standard for all medical device manufacturers who distribute in Canada, including those with existing marketed products. As a result, there has been a large...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.